NYSEARCA:XBI SPDR S&P Biotech ETF Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding SPDR S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. $77.06 +0.83 (+1.09%) (As of 06/24/2022 04:00 PM ET) Add Share Today's Range$74.29▼$77.6550-Day Range$62.81▼$87.7752-Week Range$61.78▼$141.50Volume18.56 million shsAverage Volume14.58 million shsMarket Capitalization$5.97 billionP/E RatioN/ADividend Yield0.00%Price TargetN/A ProfileChartDividendInstitutional OwnershipHeadlinesOptions ChainSocial Media View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive XBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SPDR S&P Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Basic Details Issuer SSgA Fund NameSPDR S&P Biotech ETF Tax ClassificationRegulated Investment Company SymbolNYSEARCA:XBI Inception Date1/31/2006 Fund ManagerMichael Feehily, Karl Schneider, Raymond Donofrio Webwww.spdrs.com Phone+1-866-7872257Fund Focus Asset ClassEquity BenchmarkS&P Biotech Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Fund Statistics Assets Under Management$7.17 billion Average Daily Volume$13.70 million Discount/Premium-0.10% ETF Expenses Management Fee0.35% Other Expenses0.00% Total Expenses0.35% Fee Waiver0.00% Net Expenses0.35%Administrator, Advisor and Custodian AdministratorSSgA Funds Management, Inc. AdvisorSSgA Funds Management, Inc. CustodianState Street Bank and Trust Company DistributorState Street Global Advisors Funds Distributors, LLC Transfer AgentState Street Bank and Trust Company Trustee Lead Market MakerVirtu Financial Geographic Exposure of XBICurrency Exposure of XBISector Exposure of XBIIndustry Exposure of XBI SPDR S&P Biotech ETF Frequently Asked Questions How has SPDR S&P Biotech ETF's stock performed in 2022? SPDR S&P Biotech ETF's stock was trading at $111.96 on January 1st, 2022. Since then, XBI shares have decreased by 31.2% and is now trading at $77.06. View the best growth stocks for 2022 here. Who are SPDR S&P Biotech ETF's key executives? SPDR S&P Biotech ETF's management team includes the following people: James E. Ross, President, Trustee (Age 52)Peter A. Ambrosini, Chief Compliance Officer (Age 69)Michael P. Riley, Vice President (Age 44)Gary L. French, Treasurer (Age 64)John W. Clark, Assistant Treasurer (Age 46)Matthew W. Flaherty, Assistant Treasurer (Age 42)Chad C. Hallett, Assistant Treasurer of Street tracks series trust (Age 47)Mary Moran Zeven, Secretary (Age 52)Scott M. Zoltowski, Assistant Secretary (Age 44)Dave Kelly, Independent Trustee What other stocks do shareholders of SPDR S&P Biotech ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Biotech ETF investors own include Intel (INTC), NVIDIA (NVDA), Pfizer (PFE), Gilead Sciences (GILD), iShares Biotechnology ETF (IBB), Walt Disney (DIS), Micron Technology (MU), Cisco Systems (CSCO), AbbVie (ABBV) and Netflix (NFLX). What is SPDR S&P Biotech ETF's stock symbol? SPDR S&P Biotech ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI." Who are SPDR S&P Biotech ETF's major shareholders? SPDR S&P Biotech ETF's stock is owned by a number of institutional and retail investors. Top institutional investors include Goldman Sachs Group Inc. (0.00%), Jane Street Group LLC (0.00%), Matrix Capital Management Company LP (2.52%), Clal Insurance Enterprises Holdings Ltd (2.64%), Twin Tree Management LP (0.00%) and Healthcare of Ontario Pension Plan Trust Fund (1.00%). Which institutional investors are selling SPDR S&P Biotech ETF stock? XBI stock was sold by a variety of institutional investors in the last quarter, including Healthcare of Ontario Pension Plan Trust Fund, Goldman Sachs Group Inc., BlackRock Inc., Bank of Nova Scotia, UBS Group AG, Bank of America Corp DE, Cutler Group LP, and HAP Trading LLC. Which institutional investors are buying SPDR S&P Biotech ETF stock? XBI stock was purchased by a variety of institutional investors in the last quarter, including Matrix Capital Management Company LP, Clal Insurance Enterprises Holdings Ltd, Twin Tree Management LP, Northwestern Mutual Wealth Management Co., Jane Street Group LLC, Q Global Advisors LLC, Blackstone Inc., and Main Management ETF Advisors LLC. How do I buy shares of SPDR S&P Biotech ETF? Shares of XBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is SPDR S&P Biotech ETF's stock price today? One share of XBI stock can currently be purchased for approximately $77.06. How much money does SPDR S&P Biotech ETF make? SPDR S&P Biotech ETF (NYSEARCA:XBI) has a market capitalization of $5.97 billion. How can I contact SPDR S&P Biotech ETF? SPDR S&P Biotech ETF's mailing address is One Lincoln Street, Boston, 02111, United States. The official website for SPDR S&P Biotech ETF is www.spdrs.com. The exchange traded fund can be reached via phone at +1-866-7872257. This page (NYSEARCA:XBI) was last updated on 6/24/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here